This topic contains a solution. Click here to go to the answer

Author Question: The independent variable in the experiment described in question 38 is a. the drug b. the ... (Read 9 times)

captainjonesify

  • Hero Member
  • *****
  • Posts: 543
The independent variable in the experiment described in question 38 is
 
  a. the drug
  b. the placebo
  c. blood glucose level
  d. not present

Question 2

A drug and a placebo are compared for treating diabetes. A random half of the subjects receive the drug, while the other half receives the placebo. Blood glucose level is tested in all of the subjects several times a day. What type of design does this study represent?
 
  a. Single-factor within-subjects
  b. Single-factor between subjects
  c. One-group pretest-posttest
  d. Posttest-only design with nonequivalent control groups



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

Danny Ewald

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

a

Answer to Question 2

b




captainjonesify

  • Member
  • Posts: 543
Reply 2 on: Jun 20, 2018
Wow, this really help


cam1229

  • Member
  • Posts: 329
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Each year in the United States, there are approximately six million pregnancies. This means that at any one time, about 4% of women in the United States are pregnant.

Did you know?

There are 20 feet of blood vessels in each square inch of human skin.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library